In our study, a reverse association was found between hypermethylation of MEF2C-AS1 and DSS in CRC patients, revealing the value in developing predictive prognostic models integrating molecular biomarkers with age, TNM stage, or other clinical characteristics [39]. The gene discussed is MEF2C; the disease is colorectal carcinoma.